Who Owns Perspective Therapeutics Stock?
NYSE: CATXHealthcareMedical DevicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 86.01%
- Held by insiders
- 8.23%
- Institutional holders
- 173
- Institutions 86.0%
- Insiders 8.2%
- Public and other 5.8%
Who owns Perspective Therapeutics stock?
Institutional investors own about 86.0% of Perspective Therapeutics's shares, spread across 173 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 8.23% of CATX.
The largest institutional holders are Blackrock Inc. (8.32%), TCG Crossover Management, LLC (6.93%) and Commodore Capital Lp (5.55%). Together, the top 10 institutions control 50.1% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their CATX positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CATX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 9.49M | 8.32% | +77.5% |
| TCG Crossover Management, LLC | 7.92M | 6.93% | 0.0% |
| Commodore Capital Lp | 6.34M | 5.55% | 0.0% |
| Avidity Partners Management, LP | 6.30M | 5.52% | +4.1% |
| State Street Corporation | 6.05M | 5.30% | +93.2% |
| Millennium Management Llc | 4.91M | 4.30% | +21.4% |
| Vanguard Capital Management LLC | 4.44M | 3.89% | +1.3% |
| Affinity Asset Advisors, Llc | 4.21M | 3.69% | +33.2% |
| Citadel Advisors Llc | 3.81M | 3.33% | +6.7% |
| Spruce Street Capital LP | 3.69M | 3.24% | +40.6% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CATX
| Fund | Shares | % Held |
|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 4.26M | 3.73% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.31M | 2.90% |
| iShares Trust-iShares Russell 2000 ETF | 2.61M | 2.28% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.13M | 0.99% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.02M | 0.89% |
| iShares Trust-iShares Russell 2000 Value ETF | 967.45K | 0.85% |
| iShares Trust-iShares Biotechnology ETF | 672.20K | 0.59% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 422.18K | 0.37% |
| SCHWAB STRATEGIC TRUST-Schwab U.S. Small-Cap ETF | 405.06K | 0.35% |
| iShares Trust-iShares Micro-Cap ETF | 349.35K | 0.31% |
Frequently asked questions
Who is the largest shareholder of Perspective Therapeutics?
Blackrock Inc. is the largest institutional shareholder of CATX, owning 8.32% of shares outstanding (9.49M shares) as of its latest 13F filing.
What percentage of Perspective Therapeutics is owned by institutions?
Institutions own about 86.0% of CATX shares and 93.7% of the public float.
How much of Perspective Therapeutics do insiders own?
Insiders, such as officers and directors, own about 8.23% of CATX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.